...
首页> 外文期刊>American Journal of Physiology >Mechanism of vasopressin natriuresis in the dog: role of vasopressin receptors and prostaglandins.
【24h】

Mechanism of vasopressin natriuresis in the dog: role of vasopressin receptors and prostaglandins.

机译:犬血管加压素钠尿的机制:血管加压素受体和前列腺素的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Renal effects of physiological amounts of vasopressin were studied in conscious dogs during servocontrolled overhydration (2% body wt). During infusion of vasopressin (50 pg . min-1 . kg body wt-1), plasma vasopressin concentration increased to 2.30 +/- 0.20 pg/ml compared with 0.12 +/- 0.03 pg/ml during control (water diuresis). With vasopressin infusion, urine flow was significantly lower (0.30 +/- 0.10 ml/min) and sodium excretion (UNaV) was significantly higher (58.0 +/- 15.8 micromol/min) than without vasopressin (4.6 +/- 0.4 ml/min and 14.4 +/- 4.1 micromol/min, respectively). Deamino-[Cys1,D-Arg8]vasopressin, a V2 receptor agonist (4 pg . min-1 . kg-1), mimicked the antidiuretic response (0.20 +/- 0.03 ml/min) without changing UNaV (9.7 +/- 4.4 micromol/min). Indomethacin given during arginine vasopressin (AVP) infusion suppressed prostaglandin E2 excretion, intensified the antidiuresis (0.10 +/- 0.02 ml/min), and abolished the natriuresis (13.4 +/- 3.7 micromol/min). During AVP infusion, UNaV was highly correlated (r = 0.85) with prostaglandin E2 excretion. Blood pressure, glomerular filtration rate, plasma atrial natriuretic peptide concentration, and the rate of proximal tubule reabsorption (derived from lithium clearance) were similar in all series. The data indicate that, in the dog, physiological amounts of vasopressin can induce natriuresis, probably through activation of non-V2 receptors and the intrarenal synthesis of prostaglandins.
机译:在伺服控制的过度水合作用(2%体重)期间,在清醒的狗中研究了生理量的加压素对肾脏的影响。在输注加压素(50 pg。min-1。kg体重wt-1)期间,血浆加压素浓度增加至2.30 +/- 0.20 pg / ml,而对照(水利尿)期间为0.12 +/- 0.03 pg / ml。输注加压素后,尿液流量明显低于未加压素(4.6 +/- 0.4 ml / min)(0.30 +/- 0.10 ml / min),钠排泄量(UNaV)明显较高(58.0 +/- 15.8 micromol / min)。和分别为14.4 +/- 4.1 micromol / min)。 V2受体激动剂Deamino- [Cys1,D-Arg8]加压素(4 pg。min-1。kg-1)模仿抗利尿剂反应(0.20 +/- 0.03 ml / min),而未改变UNaV(9.7 +/-) 4.4微摩尔/分钟)。在输注精氨酸加压素(AVP)期间给予消炎痛抑制前列腺素E2排泄,增强抗利尿作用(0.10 +/- 0.02 ml / min),并消除利尿作用(13.4 +/- 3.7 micromol / min)。在AVP输注期间,UNaV与前列腺素E2的排泄高度相关(r = 0.85)。在所有系列中,血压,肾小球滤过率,血浆心房利钠肽浓度和近端小管重吸收率(源自锂清除率)均相似。数据表明,在狗中,生理量的加压素可能通过非V2受体的激活和前列腺素的肾内合成来诱导利尿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号